North Star Asset Management Inc Gilead Sciences, Inc. Transaction History

North Star Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$64.88 - $73.64 $215,531 - $244,632	-3,322 Closed	0 $0
Q3 2021 Oct 20, 2021	SELL	$67.69 - $73.03 $17,464 - $18,841	-258 Reduced 7.21%	3,322 $232,000
Q2 2021 Jul 30, 2021	SELL	$63.47 - $69.35 $49,189 - $53,746	-775 Reduced 17.8%	3,580 $247,000
Q1 2021 Apr 29, 2021	BUY	$60.0 - $68.46 $261,300 - $298,143	4,355 New	4,355 $281,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of North Star Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on North Star Asset Management Inc with notifications on news.